Literature DB >> 9088793

Hemodynamic effects of intravenous morphine infusion in ventilated preterm babies.

G Sabatino1, L Quartulli, S Di Fabio, L A Ramenghi.   

Abstract

BACKGROUND: the importance of sedation and analgesia of newborn babies in intensive care is only now receiving recognition in many neonatal units.
OBJECTIVE: to evaluate the hemodynamic effects of morphine on Cerebral Blood Flow velocities (CBFv), Cardiac Output (CO), Stroke Volume (SV), Mean Arterial Blood Pressure (MABP) and Heart Rate (HR) in ventilated preterm infants, before and during the infusion of a loading dose.
DESIGN: prospective, open, non-randomized, before-after intervention study with hemodynamic measurements made by Doppler ultrasound.
SETTING: neonatal Intensive Care Unit, Tertiary Care Center. PATIENTS: sequential sample of 30 ventilated preterm newborns (gestational age (GA) 29 +/- 2 wks, range 27-31, birth weight (BW) 1240 +/- 440 g, range 800-1680). INTERVENTION: each subject received an intravenous loading dose of morphine (100 mcg/Kg/h) for 2 h, followed by a continuous infusion of 25 mcg/kg/h. MEASUREMENTS: the following Doppler parameters of the anterior cerebral artery were estimated: Peak systolic flow velocity (Vs), end-diastolic flow velocity (Vd), mean flow velocity (Vm) and Pourcelot' Resistance Index (RI). Measurements of CBFv, CO and SV (by Doppler ultrasound), MABP and HR were made 30 min before (baseline values) and at 15 (M15), 30 (M30), 60 (M60) and 120 min (M120), during the morphine loading infusion. Statistical evaluation analysis of variance, significance was calculated by Student-Newman-Kenfeld test.
RESULTS: there were no statistically significant changes in the cerebral and cardiac Doppler parameters before or during the 120 min of morphine loading infusion. There was a non-significant fall in MABP (MABP: Baseline value = 44 +/- 6 mmHg, M120 = 42 +/- 4 mmHg; reduction = 4%) and HR (HR = Baseline value = 148 +/- 12 beats/min., M120 = 140 +/- 16 beats/min.; reduction = 5%).
CONCLUSIONS: a loading dose of morphine over 2 h did not have any significant effect on MABP or cerebral and cardiac hemodynamics. No adverse effects were noted that could be attributed to morphine therapy.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9088793     DOI: 10.1016/s0378-3782(96)01781-1

Source DB:  PubMed          Journal:  Early Hum Dev        ISSN: 0378-3782            Impact factor:   2.079


  6 in total

1.  Adult responses to an ischemic stroke in a rat model of neonatal stress and morphine treatment.

Authors:  Sarah L Hays; Olga A Valieva; Ronald J McPherson; Sandra E Juul; Christine A Gleason
Journal:  Int J Dev Neurosci       Date:  2012-09-28       Impact factor: 2.457

2.  Morphine in ventilated neonates: its effects on arterial blood pressure.

Authors:  S H P Simons; D W E Roofthooft; M van Dijk; R A van Lingen; H J Duivenvoorden; J N van den Anker; D Tibboel
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2005-08-30       Impact factor: 5.747

3.  Cardiovascular effects of an intravenous bolus of morphine in the ventilated preterm infant.

Authors:  N Rutter; N Evans
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2000-09       Impact factor: 5.747

4.  Haemodynamics of intravenous paracetamol in neonates.

Authors:  Karel Allegaert; Gunnar Naulaers
Journal:  Eur J Clin Pharmacol       Date:  2010-07-04       Impact factor: 2.953

5.  Acute kidney injury in a preterm infant homozygous for the C3435T polymorphism in the ABCB1 gene given oral morphine.

Authors:  Laura Pogliani; Chiara Mameli; Dario Cattaneo; Emilio Clementi; Fabio Meneghin; Sonia Radice; Simona Bruno; Gian Vincenzo Zuccotti
Journal:  Clin Kidney J       Date:  2012-09-06

6.  Intravenous morphine versus intravenous paracetamol after cardiac surgery in neonates and infants: a study protocol for a randomized controlled trial.

Authors:  Gerdien A Zeilmaker-Roest; Joost van Rosmalen; Monique van Dijk; Erik Koomen; Nicolaas J G Jansen; Martin C J Kneyber; Sofie Maebe; Greet van den Berghe; Dirk Vlasselaers; Ad J J C Bogers; Dick Tibboel; Enno D Wildschut
Journal:  Trials       Date:  2018-06-13       Impact factor: 2.279

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.